Regenxbio Free Cash Flow from 2010 to 2025
| RGNX Stock | USD 8.70 0.46 5.58% |
Free Cash Flow | First Reported 2014-09-30 | Previous Quarter -40.9 M | Current Value -32.7 M | Quarterly Volatility 60.4 M |
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17 M, Interest Expense of 16.3 M or Selling General Administrative of 50.8 M, as well as many indicators such as Price To Sales Ratio of 4.36, Dividend Yield of 0.0 or PTB Ratio of 1.55. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
Regenxbio | Free Cash Flow |
Latest Regenxbio's Free Cash Flow Growth Pattern
Below is the plot of the Free Cash Flow of Regenxbio over the last few years. It is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets. Regenxbio's Free Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
| Free Cash Flow | 10 Years Trend |
|
Free Cash Flow |
| Timeline |
Regenxbio Free Cash Flow Regression Statistics
| Arithmetic Mean | (58,909,434) | |
| Geometric Mean | 33,996,724 | |
| Coefficient Of Variation | (179.30) | |
| Mean Deviation | 82,757,989 | |
| Median | (23,037,000) | |
| Standard Deviation | 105,624,269 | |
| Sample Variance | 11156.5T | |
| Range | 372.9M | |
| R-Value | (0.57) | |
| Mean Square Error | 8017.4T | |
| R-Squared | 0.33 | |
| Significance | 0.02 | |
| Slope | (12,730,603) | |
| Total Sum of Squares | 167347.3T |
Regenxbio Free Cash Flow History
Other Fundumenentals of Regenxbio
Regenxbio Free Cash Flow component correlations
About Regenxbio Financial Statements
Regenxbio investors use historical fundamental indicators, such as Regenxbio's Free Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Free Cash Flow | -175.6 M | -166.8 M | |
| Free Cash Flow Yield | (0.46) | (0.44) | |
| Free Cash Flow Per Share | (3.55) | (3.72) | |
| EV To Free Cash Flow | (2.32) | (2.44) | |
| Price To Free Cash Flows Ratio | (2.18) | (2.29) | |
| Free Cash Flow Operating Cash Flow Ratio | 1.01 | 1.17 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Regenxbio Stock Analysis
When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.